TY - CONF T1 - A phase I/II feasibility study of cetuximab with 5FU and mitomycin C or cisplatin with concurrent radiotherapy in muscle invasive bladder cancer JO - JOURNAL OF CLINICAL ONCOLOGY PY - 2020/01/01 AU - James ND AU - Pirrie S AU - Liu W AU - Ford D AU - Zarkar A AU - Southgate E AU - Desai A AU - Hussain SA ED - VL - 38 IS - 6 Y2 - 2025/07/20 ER -